Solange Peters(@peters_solange) 's Twitter Profileg
Solange Peters

@peters_solange

Medical Oncology Chair @CHUVLausanne,@ETOP_eu,@myESMO,@IASLC,@Women4Oncology, ESMO 20-23 President. Views expressed here are my own 🪜

ID:2852252002

linkhttp://esmo.org/About-Us/How-We-Work/ESMO-Election-2020-2021/Presidential-Vision-of-Solange-Peters calendar_today30-10-2014 21:26:44

4,8K Tweets

10,3K Followers

841 Following

Follow People
Eric Topol(@EricTopol) 's Twitter Profile Photo

So many great folks and friends in this group promoting human health, honored to be among them
time.com/collection/tim… TIME TIMEHealth

So many great folks and friends in this group promoting human health, honored to be among them time.com/collection/tim… @TIME @TIMEHealth #TIME100HEALTH
account_circle
David Gandara(@drgandara) 's Twitter Profile Photo

Solange Peters selected Lung Cancer Giant of Cancer Care 2024! I am asked to describe her in 3 words: Exceptional, Exceptional, Exceptional! There is a reason the NIH added this category as better than Outstanding. PER OncLive.com

account_circle
Dr. Amy C. Moore(@acmoorephd) 's Twitter Profile Photo

Congratulations to Dr. Solange Peters for her selection as one of this year’s “Giants of Cancer Care.” She will be the keynote speaker for LUNGevity Foundation’s , being held virtually Sept 20-21, 2024. onclive.com/view/giants-of…

account_circle
OncoAlert(@OncoAlert) 's Twitter Profile Photo

The OncoAlert 🚨Network Warmly extends its congratulations to Two of our Distinguished Faculty, part of our Founding faculty and ESMO - Eur. Oncology Presidents:

⚕️ Solange Peters 🇨🇭 from CHUV / Centre hospitalier universitaire vaudois
⚕️ FabriceAndre 🇫🇷 from Gustave Roussy

Named Giants of Cancer Care, an award that…

The @OncoAlert 🚨Network Warmly extends its congratulations to Two of our Distinguished Faculty, part of our Founding faculty and @myESMO Presidents: ⚕️ @peters_solange 🇨🇭 from @CHUVLausanne ⚕️ @FAndreMD 🇫🇷 from @GustaveRoussy Named Giants of Cancer Care, an award that…
account_circle
International Lung Cancer Summit(@LungSummit) 's Twitter Profile Photo

See the statement by ETOP IBCSG Partners Foundation on the future directions of ADCs in breast & lung cancer treatment, & the need for collaborative efforts to optimize therapy.

In Annals of Oncology by Solange Peters, Sherene Loi, MD, Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ, Rolf Stahel & colleagues ⬇️ annalsofoncology.org/article/S0923-…

account_circle
Hidehito HORINOUCHI(@HHorinouchi) 's Twitter Profile Photo

⏰NOW OUT‼️ Abstract Titles
🔥Lung Cancer - Rapid Oral NSCLC Metastatic
☑️#8513 Sunvozertinib Dr.James CH Yang
☑️#8514 Zongertinib Dr.John Heymach
☑️#8520 Taletrectinib Dr.Wei Li
☑️#8521 SGNB6A-001 Solange Peters
and others
OncoAlert ASCO

⏰NOW OUT‼️#ASCO24 Abstract Titles 🔥Lung Cancer - Rapid Oral NSCLC Metastatic ☑️#8513 Sunvozertinib Dr.James CH Yang ☑️#8514 Zongertinib Dr.John Heymach ☑️#8520 Taletrectinib Dr.Wei Li ☑️#8521 SGNB6A-001 @peters_solange and others #LCSM @OncoAlert @ASCO
account_circle
OncoAlert(@OncoAlert) 's Twitter Profile Photo

Out on Annals of Oncology Review Peper on ADC💊in 🫁& : A position statement from ETOP IBCSG Partners Foundation Partnered foundation

The rapid evolution of antibody-drug conjugates (ADCs) in cancer therapy necessitates biomarker-driven strategies, optimized treatment…

Out on @Annals_Oncology Review Peper on ADC💊in #LungCancer 🫁& #BreastCancer : A position statement from @etop_ibcsg Partnered foundation The rapid evolution of antibody-drug conjugates (ADCs) in cancer therapy necessitates biomarker-driven strategies, optimized treatment…
account_circle
OncoDaily(@oncodaily) 's Twitter Profile Photo

🚨 New Paper Alert! 🚨
A Comprehensive Review of ADCs in Lung and Breast Cancer by the ETOP IBCSG Partners Foundation

oncodaily.com/54546.html

ESMO - Eur. Oncology Annals of Oncology

Authors: Solange Peters, Sherene Loi, MD, FabriceAndre, Sarat Chandarlapaty, Enriqueta Felip, Stephen Finn, Pasi…

account_circle
Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ(@APassaroMD) 's Twitter Profile Photo

🚀 Just out in Annals of Oncology: ETOP IBCSG Partners Foundation's position statement on antibody-drug conjugates (ADC) in lung and breast cancer.
Honored to be a part of it, diving into the current evidence & future directions for clinical ADC development
annalsofoncology.org/article/S0923-…

🚀 Just out in @Annals_Oncology: @etop_ibcsg's position statement on antibody-drug conjugates (ADC) in lung and breast cancer. Honored to be a part of it, diving into the current evidence & future directions for clinical ADC development annalsofoncology.org/article/S0923-…
account_circle
d.planchard(@dplanchard) 's Twitter Profile Photo

While we await the opening of our future Gustave metro station, the new medical oncology department opened. It's a really nice architectural renovation, and it's great to have the whole department on the same floor! Thanks to our management Gustave Roussy Gustave Roussy Alumni

While we await the opening of our future Gustave metro station, the new medical oncology department opened. It's a really nice architectural renovation, and it's great to have the whole department on the same floor! Thanks to our management @GustaveRoussy @GRAlumni
account_circle
OncoAlert(@OncoAlert) 's Twitter Profile Photo

Just Out
U.S. FDA 🇺🇸 approves alectinib for adjuvant treatment following tumor resection in patients with ALK positive non-small cell lung cancer 🫁 Based on Results from ALINA

fda.gov/drugs/resource…

Christian Rolfo gilberto lopes Narjust Florez, MD, FASCO Stephen V Liu, MD H. Jack West, MD

Just Out @US_FDA 🇺🇸 approves alectinib for adjuvant treatment following tumor resection in patients with ALK positive non-small cell lung cancer #NSCLC 🫁 Based on Results from ALINA fda.gov/drugs/resource… @ChristianRolfo @GlopesMd @NarjustFlorezMD @StephenVLiu @JackWestMD…
account_circle
Myriam Chalabi(@MyriamChalabi) 's Twitter Profile Photo

What happens in Zurich….goes to ! Fantastic meeting and discussions for the educations, together with my scientific co-chair Toni Choueiri, MD ! New tracks, new concepts and the best experts! Mark your agendas for ! ESMO - Eur. Oncology

What happens in Zurich….goes to #ESMO25 ! Fantastic meeting and discussions for the educations, together with my scientific co-chair @DrChoueiri ! New tracks, new concepts and the best experts! Mark your agendas for #Berlin! @myESMO
account_circle
Ben Solomon(@bensolomon1) 's Twitter Profile Photo

Alectinib in Resected ALK-Positive Non–Small-Cell Lung Cancer | New England Journal of Medicine nejm.org/doi/full/10.10…

account_circle
Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ(@APassaroMD) 's Twitter Profile Photo

🛎 just published in NEJM our editorial on the groundbreaking ALINA trial, evaluating the role of adjuvant alectinib in patients with resected NSCLC carrying ALK rearrangements.
A major advance for our patients!
🔗nejm.org/doi/full/10.10…

🛎 just published in @NEJM our editorial on the groundbreaking ALINA trial, evaluating the role of adjuvant alectinib in patients with resected NSCLC carrying ALK rearrangements. A major advance for our patients! 🔗nejm.org/doi/full/10.10…
account_circle
Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo

Editorial on ALINA (adjuvant alectinib for resected NSCLC) from Drs. Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ Solange Peters in NEJM. Acknowledge discussions of survival, optimal duration, testing, and role of chemotherapy in the context of highly effective targeted therapy.

nejm.org/doi/full/10.10…

account_circle
Anirban Maitra(@Aiims1742) 's Twitter Profile Photo

Out in nature concurrent with
Two papers on biochemistry and preclinical characterization of Revolution Medicines’ RAS(ON) multiRAS inhibitor, with a focus on
KenOliveLab Ben Stanger Der Lab at UNC
nature.com/articles/s4158…
nature.com/articles/s4158…

account_circle
Cell(@CellCellPress) 's Twitter Profile Photo

Special content from our anniversary focus issue on by Solange Peters CHUV / Centre hospitalier universitaire vaudois & colleagues: 'Cancer biomarkers: Emerging trends and clinical implications for personalized treatment'

Read the review: cell.com/cell/fulltext/…

account_circle